![]() ![]() And Sattaru said, plans were afoot to develop a digital ecosystem around this product in the coming year. The pandemic has seen consumers and doctors becoming more open to digital options like tele-consultations and wearable technologies that help keep a tab on one’s health. A quick scan of the sensor with a reader provides a real-time glucose reading on demand and a complete picture of a person’s glucose levels, without painful, routine finger-pricks or daily calibration, it added. The FreeStyle Libre sensor measures glucose every minute in interstitial fluid through a small (5.5mm long) filament inserted just under the skin and held in place with a small adhesive pad, the company explained. India is home to the second largest number of people with diabetes in the world, after China. This is of particular importance during the pandemic, given the heightened risk for people with diabetes. The device can be used on young children above the age of four years, in women with gestational diabetes (during pregnancy) and in those with Type II diabetes, keen on keeping their diabetes under control. Sattaru explains that the product would be helpful for those with Type 1 diabetes, for instance, where parents are able to monitor sugar levels of their children when they play or sleep. The sensor gives continuous readings for 14 days and analytics that cover a three-month period, mapping the sugar levels against diet, exercise etc. The reader is a one-time cost to the consumer at ₹5,500 and the sensor is a recurring cost of ₹5,000, possibly every three months. Price factorīut can the benefit of being aware of the dangerous dip in sugar levels, particularly at night or wee hours of the morning, be blunted by the price of the device? There is no need to buy additional readers for the patients.Īpparently, one of the reasons to use Libre Pro is not to overload patients with continuous glucose numbers, and to make sure that the patients don’t change their usual behaviour when wearing the sensor - if the goal is to obtain realistic data.The product includes a coin-size sensor that is fixed onto the upper-arm and a reader, that helps the person monitor their sugar levels continuously and share with a doctor. The clinic will only need one reader, which also costs around $66. Libre Pro is much cheaper than traditional continuous glucose monitoring: the cost of each sensor is around 60 euros ($66), and it lasts for two weeks. It is easier to get a regulatory approval for this simplified system. Libre Pro doesn’t present any risk to the patient.The only difference: you can scan Libre and see the latest data in any given moment, and Libre will additionally store the data of manual scans. Both systems measure glucose in the interstitial fluid every minute, and both systems will store long-term data points every 15 minutes.If using Libre Pro, the patient only has the sensor and no reader. The patient can use the Libre reader as a glucose meter and as a ketone meter. Another feature of the Libre’s reader is a hidden bolus calculator which needs to be set up by a medical professional. There is an option to add bookmarks about food and exercise for an easier interpretation of glucose data afterwards. Libre has features that help with diabetes self-management.The goal of Libre Pro is to provide data to medical professionals. ![]() The goal of Libre is to help with self-management of diabetes, to assist with real-time decisions which we make during the day.The doctor scans the sensor using a Libre Pro reader and downloads the complete glucose data for two weeks. After 14 days, the patient comes back to the doctor’s office.Over 14 days, the sensor collects glucose readings every 15 minutes.The sensor is water-resistant and doesn’t need any special attention. The patient wears the sensor for up to 14 days.In the clinic, a medical professional applies a small Libre Pro sensor to the patient’s upper arm.Only clinicians can see and analyse the data. The patients wearing the Pro sensor cannot see any data collected by this device. This is a novel “flash” glucose monitoring system that measures glucose every 15 minutes and does not require any manual calibration. In September 2016, US FDA has approved Abbott’s Freestyle Libre Pro, a version of Freestyle Libre for medical professionals. Abbott’s Freestyle Libre flash glucose monitoring sensor (image by Abbott) ![]()
0 Comments
Leave a Reply. |